Skip to main content
Caplin Point Laboratories Ltd. logo

Caplin Point Laboratories Ltd. — Investor Relations & Filings

Ticker · CAPLIPOINT ISIN · INE475E01026 LEI · 33580043U3LXMROY5J69 BSE.NS Manufacturing
Open in API
Filings indexed 697 across all filing types
Latest filing 2026-05-14 Audit Report / Informat…
Country IN India
Listing BSE.NS CAPLIPOINT

About Caplin Point Laboratories Ltd.

https://www.caplinpoint.net

Caplin Point Laboratories Ltd. is a pharmaceutical organization focused on the development, manufacturing, and marketing of finished dosage forms. Its extensive product portfolio encompasses tablets, capsules, injections, liquid orals, and softgel capsules across diverse therapeutic categories. The company utilizes a vertically integrated business model, overseeing the complete value chain from research and development to final distribution. Caplin Point maintains a significant market presence in Latin America and Francophone Africa, supported by a specialized end-to-end logistics and supply chain network. Furthermore, through its subsidiary Caplin Steriles, the company has established a footprint in regulated markets, specializing in sterile injectables and ophthalmic products. Its manufacturing infrastructure is designed to meet global regulatory requirements, including certifications from the US FDA and EU GMP.

Recent filings

Filing Released Lang Actions
The Board at its meeting held today, May 14, 2026, had declared Interim Dividend of INR.4.00 (200%) per equity share for the FY 2025-26 and fixed the Record date as May 30, 2026.
Audit Report / Information Classification · 86% confidence The filing is a detailed Independent Auditor’s Report on the audited standalone and consolidated financial results of the company for the year ended March 31, 2026, complete with audit opinion, basis for opinion, management’s responsibilities, and other standard audit report sections. It is not a full annual report (10-K), nor merely a notice of report publication, but rather the standalone audit report itself. This matches the “Audit Report / Information” category (AR).
2026-05-14 English
Record Date
Audit Report / Information Classification · 82% confidence The document is an official SEBI LODR filing containing the ‘Outcome of Board Meeting’ letter and, as Annexure-1, the full Independent Auditor’s Report on the audited consolidated quarterly and annual financial results for the year ended March 31, 2026. The core of the text is the standalone audit report (opinion, basis, responsibilities), which fits the definition of a standalone audit report (Code: AR).
2026-05-14 English
Financial Results for the Quarter and Year ended March 31, 2026
Audit Report / Information Classification · 85% confidence The document is the formal outcome of a Board meeting to approve interim dividends and audited financial results, but the bulk of the text is the independent auditor’s report on the consolidated quarterly and annual financial results pursuant to SEBI Regulation 33. It contains detailed audit opinion, basis for opinion, management and auditor responsibilities, and other audit report components. This matches the definition of a standalone Audit Report / Information (code AR).
2026-05-14 English
Dividend
Regulatory Filings
2026-05-14 English
The Board at its meeting held today, May 14, 2026, had 1. Approved the Audited standalone and consolidated financial results of the Company for the year ended March 31, 2026, along with ....
Regulatory Filings Classification · 62% confidence The document is an Indian securities exchange filing announcing the outcome of a Board meeting (Regulation 30/33 disclosure), including approval of audited standalone and consolidated financial results for the year ended March 31, 2026, declaration of an interim dividend and record date, plus auditor’s report, press release and investor presentation. It is not the full Annual Report (10-K), nor is it solely an interim/quarterly report (IR) or dividend notice (DIV), and it is more than a simple report publication announcement (RPA). It therefore falls under general regulatory announcements to exchanges and is classified as a Regulatory Filing (RNS).
2026-05-14 English
Outcome of Board Meeting
Audit Report / Information Classification · 80% confidence The document is a stock‐exchange filing notifying regulators of the Board Meeting outcome, which includes approval of the audited standalone and consolidated financial results along with the Independent Auditor’s Report pursuant to SEBI Reg.33. It is not a full Annual Report (10‐K) nor merely a dividend notice or investor presentation. Instead, it primarily embeds the Independent Auditor’s Report on the financial results, fitting the ‘Audit Report / Information’ definition (Code: AR).
2026-05-14 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.